U Of Arizona research widens the pesticide risk window — but regulation still starts too late

The u of arizona is at the center of a study that challenges a core assumption embedded in many public-health conversations: that the main window of concern begins only after pregnancy is confirmed. By linking state birth records with Arizona’s pesticide use registry, researchers found that living near agricultural pesticide applications in the 90 days before conception and during pregnancy was associated with increased odds of low five-minute Apgar scores—an early-life metric tied to later health outcomes.

What did the u of arizona study measure—and why does “before pregnancy” matter?

The research, published in the Journal of Exposure Science & Environmental Epidemiology, examined whether residential proximity to agricultural pesticide applications during preconception and pregnancy was associated with newborn Apgar scores. The analysis used pesticide use registry data and birth certificate data from 2006 to 2020, linked through the Arizona Pregnant Women’s Environmental and Reproductive Outcomes Study (Az-PEARS).

Exposure was defined as living within 500 meters of an agricultural pesticide application during preconception—labeled T0 and defined as 90 days before conception—and during each trimester (T1 through T3). The outcome was the five-minute Apgar score categorized as low (< 8) or high (≥8). Researchers applied log-binomial regression and a meta-analytic approach to estimate adjusted odds ratios and 95% confidence intervals, adjusting for newborn and maternal demographics.

included with the study coverage, Melissa Furlong, assistant professor at the Mel and Enid Zuckerman College of Public Health and senior author, framed the rationale bluntly: pesticides are designed to be toxic and can have demonstrable biological effects on human health. Audrey Yang, a graduate student at the College of Medicine – Tucson and the study’s first author, emphasized what the team described as the novel element: identifying the preconception period as a possible sensitive window of exposure for some commonly used pesticides.

Which pesticides were linked to low Apgar scores—and how strong were the associations?

The study evaluated carbamate, organophosphate, and pyrethroid pesticide classes and 25 individual active ingredients. It found that exposure to several specific active ingredients at any point during preconception and/or pregnancy was associated with increased odds of low Apgar scores. The reported adjusted odds ratios (aOR) and 95% confidence intervals (CI) included:

• Carbaryl (carbamate): aOR 2. 07 (95% CI: 1. 45, 2. 96)
• Formetanate hydrochloride (carbamate): aOR 3. 50 (95% CI: 1. 55, 7. 89)
• Diazinon (organophosphate): aOR 1. 67 (95% CI: 1. 25, 2. 22)
• Tribufos (organophosphate): aOR 1. 39 (95% CI: 1. 02, 1. 90)
• Cypermethrin (pyrethroid): aOR 1. 49 (95% CI: 1. 03, 2. 15)

The researchers also observed consistent effect estimates across trimesters. Additional positive associations were described for ethephon, phorate, and beta-cyfluthrin during T0; methomyl during T1; and esfenvalerate and fenpropathrin during T2.

Descriptively, the underlying birth population included newborns that were approximately half male, with the majority born at 38 weeks of gestation or later. Mothers were predominantly ages 20–35 and non-Hispanic white, as described in the study summary.

Verified fact: the study reports statistical associations between defined proximity-based exposure windows and a dichotomized five-minute Apgar score outcome, expressed as adjusted odds ratios for individual active ingredients and pesticide classes.

Informed analysis: the strongest contradiction exposed by these results is procedural rather than academic: a health-risk window identified as “preconception” sits outside the moment many systems treat as the start of pregnancy-related prevention, counseling, and oversight.

Who holds the data—and what does that mean for accountability?

A key structural element of this work is the availability of detailed pesticide application records. The researchers drew from the Arizona pesticide registry, described as comprehensive records of every pesticide application made across the state, including crop type, pests, brand name, and active ingredient. The study coverage notes that Arizona is one of two states in the U. S. that maintain pesticide use registries. The team linked those registry records with all birth certificate records from the state of Arizona.

This linkage is the practical mechanism that makes the preconception finding visible. Without a registry capable of pinpointing where and when pesticides were applied—along with a dataset capturing pregnancy and birth outcomes—the question of “before pregnancy” exposure can remain rhetorically compelling but empirically untestable at scale.

Stakeholders implicated by the findings fall into at least three categories:

• Public health and academic researchers who can identify sensitive windows and ingredient-specific signals, but who also must communicate limits clearly.
• Regulatory and legislative actors who can respond with ingredient-level rules or initiatives if evidence warrants.
• Clinical practitioners who may need to treat environmental history—including residential proximity and timing—as relevant to care.

Furlong’s comments underscore an ingredient-specific policy approach rather than a blanket prohibition, arguing that alternatives often exist and that not all pesticides are equally toxic. Yang’s comments point to the clinical side: the importance of sharing environmental history with doctors.

What the study does not claim—and what comes next

The study coverage explicitly states a limitation that often gets lost once a finding enters public debate: the research identifies a strong correlation but does not definitively state that pesticide exposure during preconception and pregnancy deteriorates newborn health. That distinction matters for how the public should interpret the results and for how decision-makers should weigh them against other considerations.

Researchers also described a next step: Furlong’s group plans to look at Medicaid records in the state of Arizona to examine whether the association holds for actual neurodevelopmental disorders through childhood.

Verified fact: the study’s design uses proximity within 500 meters of applications as a binary exposure measure across T0 and trimesters, and it reports ingredient-specific associations with low five-minute Apgar scores.

Informed analysis: the central tension is that exposure mitigation strategies often begin with pregnancy recognition, while this work highlights a period—90 days before conception—where risk signals appear for some ingredients. If that window is real, the responsibility for prevention shifts outward: from individual behavior after pregnancy confirmation to broader transparency and policy mechanisms that address exposure before pregnancy begins.

For the u of arizona team and its multi-institutional collaborators at Harvard Chan School of Public Health and UCLA Fielding School of Public Health, the study’s bottom line is not a sweeping ban but a demand for specificity: more data on ingredient-level health effects so applications can be regulated in ways that improve maternal and child health. The public question now is whether oversight, clinical practice, and policy will treat the preconception period as a real part of the risk window—or continue acting as if protection starts only after pregnancy has already begun.